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Prikaz bolesnika | Case report
Hepatitis E Induced „Acute-On-Chronic” Liver Failure 
- Do We Transplant or Not?
„Acute-on-chronic” zatajenje jetre uzrokovano hepatitis E virusnom infekcijom 
- transplantirati ili ne?
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Abstract
Hepatitis E virus is a pathogen of worldwide significance. In developed countries, foodborne transmission of zo-
onotic genotypes is the most common route of infection. Transfusion transmitted infection is also an important 
source of infection, particularly in immunocompromised population. In most cases, HEV infection is asymptomat-
ic or presents as an acute self-limiting hepatitis. Rarely it leads to fulminant hepatitis or „acute-on- chronic” liver 
failure in people with pre-existing chronic liver diseases. The aim of this report is to present the first documented 
case of HEV-related „acute-on-chronic” liver failure in Croatia in a patient with chronic liver disease listed for liver 
transplantation. Due to increasing incidence in industrialised countries, HEV infection should always be considered 
in the differential diagnosis of acute hepatitis and in patients with unexplained worsening of chronic liver disease.
Sažetak
Hepatitis E virusna (HEV) infekcija zarazna je bolest s rastućom stopom pojavnosti diljem svijeta. U razvijenim 
zemljama, najčešći put prijenosa zoonotskih genotipova HEV virusa je putem hrane, dok prijenos putem krvnih 
derivata predstavlja važan izvor infekcije u imunokompromitiranim populacijama. U većini slučajeva, HEV infekci-
ja je asimptomatska ili se uglavnom prezentira u obliku akutnog samolimitirajućeg hepatitisa, rijetko dovodeći do 
fulminantnog hepatitisa ili „acute-on-chronic” zatajenja jetre kod osoba s pre-egzistentnim bolestima jetre. Cilj 
ovog rada je prikazati prvi dokumentirani slučaj „acute-on-chronic” zatajenja jetre izazvanog HEV-om u Hrvatskoj 
kod bolesnika s kroničnom bolesti jetre koji je bio uvršten na listu za transplantaciju jetre. Zbog povećane učesta-
losti u razvijenim zemljama, HEV infekciju treba uvijek razmotriti u diferencijalnoj dijagnozi akutnog hepatitisa i 
kod bolesnika s nejasnim pogoršanjem kronične bolesti jetre.
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Introduction
 Hepatitis E has a substantial impact on human 
health affecting 3 million patients and causing 70,000 
deaths annually worldwide[1]. In developed countries, 
the most common route of infection is foodborne 
transmission of zoonotic genotypes (G 3 and 4) caused 
by consumption of raw and undercooked meat, and 
transfusion, which is important source of infection in 
immunocompromised population[2].
 In most cases, HEV infection is asymptomatic or 
presents as an acute self-limiting hepatitis, rarely lead-
ing to fulminant hepatitis or „acute-on-chronic” liver 
failure (ACLF) in people with pre-existing chronic liv-
er diseases (CLD)[3].
 In the European general population HEV seroprev-
alence rate ranges from 0.6% to 86.4% with the highest 
prevalence reported in Arie`ge in France, while the 
incidence of an acute infection ranges from 0.2% to 
3.2%[4]. However, the data on impact of acute HEV in-
fection on the prognosis and survival of pre-existing 
CLD patients in Europe is limited[6-9].
 We report the first documented case of HEV in-
duced ACLF in Croatia in a patient with previously 
undiagnosed chronic liver disease.
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was well, without signs of liver disease and his liver 
function tests were normal. Furthermore, non-inva-
sive evaluation of liver fibrosis was performed by im-
plementing transient elastography with a median liver 
stiffness of 7.5 kPa indicating stage F2 fibrosis. Finally, 
he was removed from the liver transplant waiting list.
Discussion
 This is the first documented case of HEV induced 
ACLF in Croatia, with severe clinical course which 
made him a candidate for liver transplantation. The 
vast majority of patients with HEV infection have fa-
vourable outcome and they rarely present with symp-
toms of acute hepatitis or with extrahepatic manifesta-
tions[5]. In contrast to several reports of HEV genotype 
1 and 2 induced ACLF in Asia and Africa, the burden 
and prognosis of HEV genotypes 3 and 4 in developed 
countries is unknown. Available data indicate that 
some cases of severe liver injury with adverse outcome 
among CLD patients in Europe is related to autoch-
thonous hepatitis E.
 The first documented report of liver decompen-
sation in cirrhotic patients with fatal outcome due to 
HEV infection was published in UK in 2007 by Dalton 
et al.[6]. Another study published in the same year in 
France described seven patients with fulminant liver 
failure due to HEV genotype 3 infection[7]. Six of them 
had CLD. Data from Switzerland reported severe clin-
ical course in two patients with CLD and symptomat-
ic acute HEV with fatal outcome[8]. However, a more 
recent large-scale study form the UK and France by 
Blasco-Perrin et al. found only minor (3,2%), predom-
inantly in south-west France, number of HEV cases 
among 343 patients with decompensated CLD indicat-
ing it is an uncommon cause of liver decompensation. 
Moreover, mortality was estimated to be 27% and was 
not significantly different compared to patients with-
out hepatitis E infection[9]. The incidence of HEV as 
a cause of decompensation in CLD patients consider-
ably varies geographically and probably also changes 
over time, as a reflection of the amount of circulating 
virus in a given population at a given time.
 In the presented case, risk factors for acute deterio-
ration of liver function were male gender, age and un-
derlying chronic liver disease considering liver histolo-
gy which has shown nonspecific chronic inflammation 
with marked microvesicular steatosis (with foaming 
of hepatocytes) and FibroScan measurement indicat-
ing stage F2 fibrosis. Given the patient’s medical data 
about his drinking habits and limited interpretation of 
histology in the setting of aetiology of underlying liver 
disease, it is very difficult to distinguish NAFLD from 
alcohol related CLD. In terms of making preliminary 
case report
 A 67-year-old man with one-week history of fever 
and diarrhoea was admitted to the hospital. He had 
unremarkable medical history except for asymptomat-
ic cholelithiasis and arrhythmia under good control 
with atenolol. He denied taking any drugs or herbal 
medicine, and he drank no more than two glasses of 
wine per day. A month before the onset of his symp-
toms, he travelled to Sicily.
 After admission, his liver function rapidly deterio-
rated with worsening liver function tests, as indicated 
by rising bilirubin (total bilirubin 130 μmol/L), elevat-
ed transaminases (AST 3010 U/L, ALT 4000 U/L) and 
worsening coagulopathy (INR 3.1). Infectious work up 
was negative for hepatitis A, B, C, human immuno-
deficiency virus, cytomegalovirus, and herpes simplex 
virus and positive for previous EBV infection. Blood, 
urine and bacterial stool culture were negative as were 
Clostridium difficile antigen and toxins in stool. Den-
ga virus, enteroviruses, leptospirosis, adenoviruses 
and Coxiella burnetii, as well as autoimmune liver 
panel (antinuclear antibody, anti-smooth muscle anti-
body and anti-LKM) all tested negative.
 Due to progressive deterioration of liver func-
tion the patient was urgently transferred to the Liver 
Transplant Centre. Abdominal ultrasound showed 
enlarged liver without focal lesions, normal bile ducts 
and normal hepatic blood vessels. Liver biopsy re-
vealed acute hepatitis of unknown aetiology, nonspe-
cific chronic inflammation without severe necrosis but 
with marked microvesicular steatosis (with foaming 
of hepatocytes). The patient was transferred from the 
medical ward into the Intensive care unit (ICU) due 
to deterioration. Over the next few days he developed 
hepatic encephalopathy (grade III to IV) and required 
invasive mechanical ventilation. The Multislice Com-
puted Tomography scan of the head excluded patho-
logical intracranial processes and he was listed for liver 
transplantation with MELD score of 34.
 His anti-HEV IgM and IgG resulted positive and 
the antiviral treatment with ribavirin (8mg/kg) was 
started, pending PCR analysis results. Since PCR 
HEV RNA resulted negative six days into treatment, 
ribavirin was discontinued. Management of critically 
ill patient consisted of respiratory support, parenteral 
antibiotics (cefuroxime and metronidazole), L-ornith-
ine-L-aspartate, intensive insulin therapy, mechanical 
and pharmacological thromboprophylaxis, stress ulcer 
prophylaxis and enteral feeding. Intensive care therapy 
and supportive treatment resulted in the improvement 
of the liver function (AST 185 U/L; ALT 361 U/L, total 
bilirubin 127 μmol/L, INR1.6, V factor 0.7%). Three 
months after discharge from the hospital, the patient 
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 In conclusion, since HEV infection could be asso-
ciated with significant morbidity and mortality, it is 
crucial to perform testing in all patients with symp-
toms consistent with acute hepatitis and patients with 
unexplained flares of chronic liver disease. Higher 
awareness of HEV in a differential diagnosis could re-
duce the number of cases of cryptogenic liver injury.
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diagnosis, markedly elevated liver enzymes strongly 
suggest the diagnosis to the clinician even prior ob-
tained HEV results. However, in some cases with the 
same clinical presentation, the ALT value may only be 
modestly elevated (<300) suggesting the diagnosis of 
hepatitis E in patients with decompensated CLD is not 
straightforward[9]. Moreover, considered to be mostly 
a disease of developing countries, HEV infection is still 
rarely considered in the differential diagnosis of acute 
liver failure in European countries. Drug induced liver 
injury (DILI) represents a mayor diagnostic dilemma 
when distinguishing HEV infection[3]. Another diag-
nostic difficulty is the differentiation between auto-
immune hepatitis or Epstein-Barr virus infection and 
HEV infection since both conditions can produce false 
positive HEV serology results[3]. Therefore, every pa-
tient with symptoms consistent with acute hepatitis or 
unexplained worsening of CLD should be tested both 
with PCR and serology. A negative PCR does not ex-
clude acute HEV infection[3].
 The patient was listed for liver transplantation due 
to rapid worsening of clinical condition with overt 
encephalopathy and significant coagulopathy. Man-
agement of our patient consisted of supportive treat-
ment which led to improvement of his liver function. 
In this case, the use of ribavirin did not have effect on 
the favourable outcome. The reason for this was that 
the patient was PCR negative at the time of enrolling 
ribavirin, indicating he had already achieved sponta-
neous viral clearance. However, we did not observe 
any adverse effects of treatment with ribavirin. The 
efficacy and safety of ribavirin in patients with chronic 
HEV infection was proven to be beneficial, however 
the data for patients with serious liver disease is scarce 
and needs prospective evaluation in larger population 
studies[10].
